Ahura Scientific Reaches 100-customer threshold for mobile analyzer
Used for analyzing incoming raw materials, the technology also serves product authentication purposes
Over the past four years, technology originally developed for homeland-security applications, then for explosives detection, has been adopted as a quick but accurate method for verifying the chemical supplies being shipping for pharmaceutical production. Along the way, says developer Ahura Scientific (Wilmington, MA), pharma security personnel have used the technology to verify the authenticity of products in the field—a common requirement when investigating counterfeit or diverted product.
Ahura says that as of September, its TruScan handheld instrument is in use in 100 pharma facilities, including nine of the top 10 manufacturers. “Just as companies transformed the telecommunications industry from landline to wireless and beyond, we are transforming the $40-billion analytical and life sciences instrument market to provide life-saving information in a mobile format,” said Doug Kahn, chairman and CEO.
The instrument, based on Raman spectroscopy, provides an on-the-spot analysis of raw or finished goods. It can read through packaging, including pharma blister packs, says the firm. While such devices won’t themselves secure the pharma supply chain, they can be a tool for the ongoing efforts in the industry.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
